Earnings Feed
Start Free
|4Feb 2, 5:55 PM ET

BOSHOFF CHRISTOFFEL 4

Research Summary

AI-generated summary

Updated

Pfizer (PFE) President R&D Christoffel Boshoff Withholds 12,887 Shares

What Happened
Christoffel Boshoff, President, Research & Development at Pfizer, had 12,887 restricted stock units withheld to satisfy tax obligations upon vesting. The filing shows the shares were disposed at a per-share value of $26.44, for a total value of $340,732. This is a routine tax-withholding disposition (transaction code F), not an open-market sale or purchase.

Key Details

  • Transaction date: 2026-01-30; reported on Form 4 filed 2026-02-02.
  • Price per share: $26.44; Total value of shares withheld: $340,732.
  • Shares owned after transaction: Not specified in the filing.
  • Footnote: F1 — shares were withheld to satisfy tax obligations upon RSU vesting (includes dividend equivalents).
  • Timeliness: Filed 2026-02-02; no late filing flag indicated in the provided data.

Context
Withholding shares to cover taxes on vested RSUs is a common administrative action and is generally not a directional signal about the insider’s view of the company. This was a tax withholding (cashless) disposition rather than an open-market sale.